DocuSign (DOCU) Form 144 Filed for 364 Restricted Shares
Rhea-AI Filing Summary
Form 144 notice for DocuSign, Inc. (DOCU) documents a proposed sale of 364 common shares, with an aggregate market value of $28,897.96, to be executed on 09/11/2025 on NASDAQ through Morgan Stanley Smith Barney LLC, Executive Financial Services. The shares were acquired as restricted stock from the issuer on 05/29/2025 and payment is recorded on that same date. The filing lists total outstanding shares of 201,104,117. The notice includes a representation that the seller does not possess undisclosed material information and references prior sales of 534 shares on 06/16/2025 with gross proceeds of $39,713.58.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small, routine insider sale notice relative to company capitalization; not materially market-moving.
The filing records a proposed sale of 364 restricted shares valued at $28,898, representing a de minimis fraction of the reported 201,104,117 outstanding shares. The shares were acquired from the issuer on 05/29/2025 and are slated for sale through Morgan Stanley Smith Barney on NASDAQ on 09/11/2025. Given the small absolute value and the outstanding share count, this notice appears routine and unlikely to have a material impact on valuation or trading liquidity.
TL;DR: Disclosure follows Rule 144 procedural requirements; includes standard certification about material nonpublic information.
The document provides required information about acquisition date, nature (restricted stock), broker, planned sale date, and past recent sales. It also contains the attestation that the seller is not aware of undisclosed material adverse information. From a governance and compliance perspective, the filing appears complete for the purposes of Rule 144 notice.
FAQ
What does the Form 144 for DOCU report?
Does the filing disclose any recent sales by the seller?
Who is the broker handling the proposed sale?